June 5, 2017 | Israeli startup Belkin Laser, a portfolio company of Israel’s RAD Biomed accelerator, has secured $5 million in funding from Zicom Holdings, Rimonci Capital and the European Union (grant). The capital raised adds to the $1.5 million previously raised by the company. Belkin Laser develops a laser device for glaucoma patients who will receive short, efficient treatments, instead of the eye drops used today. Belkin Laser was founded in 2013 under a license agreement from Israel’s Sheba Medical Center and Tel Aviv University. Its product is based on Prof. Michael Belkin’s invention. [Photo: TobiasD]
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Elbit Sells Air Defense System To Foreign Client For $50M
April 30, 2024
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Facebook comments